Nasdaq:US$32.17 (+0.00) | HKEX:HK$50.40 (+0.75) | AIM:£4.71 (+0.02)
News & Presentations
Previous Article   |   Next Article
Presentations, Scientific Publications | 14 Oct 2012

ISSX 2012: Pharmacokinetic/Pharmacodynamic Modeling of Epitinib to Evaluate the Anti-cancer Effect on A431 Tumor Xenograft in Nude Mice